Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
NCT ID NCT07725042
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This study aims to map the changing landscape of HIV infection in Hong Kong by analyzing the genetic subtypes and transmission patterns of the virus. Researchers will enroll 720 adults newly diagnosed with HIV to see which viral strains are most common and how they are spreading. The goal is to better understand the current epidemic and guide future prevention efforts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This could help public health officials tailor HIV prevention and treatment strategies to the current epidemic in Hong Kong.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve outcomes for participants. Results may not apply to other regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV -1 INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
S.H. Ho Research Centre for Infectious Diseases
RECRUITINGNorth Point, 0000, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo
- Long-acting HIV shot studied in patients with severe kidney problems
- RNA vaccine aims to control HIV without daily pills
- Herbal formula may help HIV patients whose immune systems Don't fully recover
- Herbal granules aim to revive immune system in HIV patients